
    
      End point: To evaluate the effect of long term administration of albumin and midodrine on the
      prevention of complications associated with cirrhosis in patients with cirrhosis awaiting for
      liver transplantation.

      Secondary end points:

        -  To evaluate improvement in the ascites control

        -  To evaluate survival at 6 and 12 months.

        -  To evaluate the relationship between the development of complications and the activity
           of vasoconstrictor systems( renin, aldosterone and norepinephrine) as well as the levels
           of cytokines (TNF, IL6 and IL10)

        -  To evaluate quality of life

        -  To evaluate the presence and outcome of MHE
    
  